{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:11:56Z","timestamp":1791159116563,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s10384-007-0487-5","type":"journal-article","created":{"date-parts":[[2008,3,27]],"date-time":"2008-03-27T16:07:02Z","timestamp":1206634022000},"page":"16-23","source":"Crossref","is-referenced-by-count":48,"title":["Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor"],"prefix":"10.1007","volume":"52","author":[{"given":"Yasuaki","family":"Hata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneki","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,28]]},"reference":[{"key":"487_CR1","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.ATV.0000176193.83629.c8","volume":"25","author":"H. Shimokawa","year":"2005","unstructured":"Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 2005;25:1767\u20131775.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"487_CR2","first-page":"1033","volume":"24","author":"T. Asano","year":"1987","unstructured":"Asano T, Ikegaki I, Satoh S, et al. Mechanism of action of a novel antivasospasm drug, HA1077. J Pharmacol Exp Ther 1987;24:1033\u20131040.","journal-title":"J Pharmacol Exp Ther"},{"key":"487_CR3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/40187","volume":"389","author":"M. Uehata","year":"1997","unstructured":"Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997;389:990\u2013994.","journal-title":"Nature"},{"key":"487_CR4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"L.P. Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480\u20131487.","journal-title":"N Engl J Med"},{"key":"487_CR5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF00193171","volume":"426","author":"Y. Hata","year":"1995","unstructured":"Hata Y, Nakagawa K, Ishibashi T, Inomata H, Ueno H, Sueishi K. Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis. Virchows Arch 1995;426:479\u2013486.","journal-title":"Virchows Arch"},{"key":"487_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2006.02.037","volume":"142","author":"Z.F. Bashshur","year":"2006","unstructured":"Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2006;142:1\u20139.","journal-title":"Am J Ophthalmol"},{"key":"487_CR7","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","volume":"351","author":"E.S. Gragoudas","year":"2004","unstructured":"Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. VEGF inhibition study in ocular neovascularization clinical trial group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805\u20132816.","journal-title":"N Engl J Med"},{"key":"487_CR8","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1182\/blood-2005-03-0889","volume":"106","author":"M. Economopoulou","year":"2005","unstructured":"Economopoulou M, Bdeir K, Cines DB, et al. Inhibition of pathologic retinal neovascularization by alpha-defensins. Blood 2005;106:3831\u20133838.","journal-title":"Blood"},{"key":"487_CR9","first-page":"626","volume":"12","author":"O. Konopatskaya","year":"2006","unstructured":"Konopatskaya O, Churchill AJ, Harper SJ, Bates DO, Gardiner TA. VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice. Mol Vis 2006;12:626\u2013632.","journal-title":"Mol Vis"},{"key":"487_CR10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2353\/ajpath.2006.050435","volume":"168","author":"T. Ojima","year":"2006","unstructured":"Ojima T, Takagi H, Suzuma K, et al. Ephrin A1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown. Am J Pathol 2006;168:331\u2013339.","journal-title":"Am J Pathol"},{"key":"487_CR11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1096\/fj.05-5046fje","volume":"20","author":"J. Shen","year":"2006","unstructured":"Shen J, Yang X, Xiao WH, Hackett SF, Sato Y, Campochiaro PA. Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization. FASEB J 2006;20:723\u2013725.","journal-title":"FASEB J"},{"key":"487_CR12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0008-6363(00)00268-6","volume":"49","author":"I. Zachary","year":"2001","unstructured":"Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 2001;49:568\u2013581.","journal-title":"Cardiovasc Res"},{"key":"487_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.ATV.0000054198.68894.88","volume":"23","author":"G.P. Nieuw Amerongen van","year":"2003","unstructured":"van Nieuw Amerongen GP, Koolwijk P, Versteilen A, van Hinsbergh VW. Involvement of RhoA\/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb Vasc Biol 2003;23:211\u2013217.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"487_CR14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2443.2005.00823.x","volume":"10","author":"M. Nakayama","year":"2005","unstructured":"Nakayama M, Amano M, Katsumi A, et al. Rho-kinase and myosin II activities are required for cell type and environment specific migration. Genes Cells 2005;10:107\u2013117.","journal-title":"Genes Cells"},{"key":"487_CR15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0092-8674(92)90163-7","volume":"70","author":"A.J. Ridley","year":"1992","unstructured":"Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992;70:389\u2013399.","journal-title":"Cell"},{"key":"487_CR16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/10739680600556944","volume":"13","author":"H. Sun","year":"2006","unstructured":"Sun H, Breslin JW, Zhu J, Yuan SY, Wu MH. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation 2006;13:237\u2013247.","journal-title":"Microcirculation"},{"key":"487_CR17","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1096\/fj.05-4240fje","volume":"19","author":"L. Zeng","year":"2005","unstructured":"Zeng L, Xu H, Chew TL, et al. HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylation. FASEB J 2005;19:1845\u20131847.","journal-title":"FASEB J"},{"key":"487_CR18","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1073\/pnas.0308525100","volume":"101","author":"M.V. Hoang","year":"2004","unstructured":"Hoang MV, Whelan MC, Senger DR. Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proc Natl Acad Sci U S A 2004;101:1874\u20131879.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"487_CR19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.RES.0000174287.17953.83","volume":"97","author":"J.M. Hyvelin","year":"2005","unstructured":"Hyvelin JM, Howell K, Nichol A, Costello CM, Preston RJ, McLoughlin P. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ Res 2005;97:185\u2013191.","journal-title":"Circ Res"},{"key":"487_CR20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1253\/circj.70.174","volume":"70","author":"K. Ishikura","year":"2006","unstructured":"Ishikura K, Yamada N, Ito M, et al. Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension. Circ J 2006;70:174\u2013178.","journal-title":"Circ J"},{"key":"487_CR21","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2005.07.047","volume":"46","author":"R.M. Vicari","year":"2005","unstructured":"Vicari RM, Chaitman B, Keefe D, et al. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebocontrolled, phase 2 trial. J. Am Coll Cardiol 2005;46:1803\u20131811.","journal-title":"Am Coll Cardiol"},{"key":"487_CR22","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/CIRCULATIONAHA.104.510248","volume":"111","author":"T. Kishi","year":"2005","unstructured":"Kishi T, Hirooka Y, Masumoto A, et al. Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure. Circulation 2005;111:2741\u20132747.","journal-title":"Circulation"},{"key":"487_CR23","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/hy1201.096541","volume":"38","author":"A. Masumoto","year":"2001","unstructured":"Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, Takeshita A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 2001;38:1307\u20131310.","journal-title":"Hypertension"},{"key":"487_CR24","doi-asserted-by":"crossref","first-page":"30336","DOI":"10.1074\/jbc.273.46.30336","volume":"273","author":"H.-P. Gerber","year":"1998","unstructured":"Gerber H-P, McMurtrey A, Kowalski J, et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3-kinase\/Akt signal transduction pathway. J Biol Chem 1998;273:30336\u201330343.","journal-title":"J Biol Chem"},{"key":"487_CR25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0014-5793(00)01657-4","volume":"477","author":"S. Dimmeler","year":"2000","unstructured":"Dimmeler S, Dernbach E, Zeiher AM. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett 2000;477:258\u2013262.","journal-title":"FEBS Lett"},{"key":"487_CR26","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI23298","volume":"115","author":"S. Nakao","year":"2005","unstructured":"Nakao S, Kuwano T, Tsutsumi-Miyahara C, et al. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J Clin Invest 2005;115:2979\u20132991.","journal-title":"J Clin Invest"},{"key":"487_CR27","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1167\/iovs.03-1092","volume":"45","author":"Y. Noda","year":"2004","unstructured":"Noda Y, Hata Y, Hisatomi T, et al. Functional properties of hyalocytes under PDGF-rich conditions. Invest Ophthalmol Vis Sci 2004;45:2107\u20132114.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"487_CR28","doi-asserted-by":"crossref","first-page":"50702","DOI":"10.1074\/jbc.M307234200","volume":"278","author":"I. Cascone","year":"2003","unstructured":"Cascone I, Giraudo E, Caccavari F, et al. Temporal and spatial modulation of Rho GTPases during in vitro formation of capillary vascular network. Adherens junctions and myosin light chain as targets of Rac1 and RhoA. J Biol Chem 2003;278:50702\u201350713.","journal-title":"J Biol Chem"},{"key":"487_CR29","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1083\/jcb.140.5.1255","volume":"140","author":"B.P. Eliceiri","year":"1998","unstructured":"Eliceiri BP, Klemke R, Stromblad S, Cheresh DA. Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 1998;140:1255\u20131263.","journal-title":"J Cell Biol"},{"key":"487_CR30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ccr.2005.12.021","volume":"9","author":"G. Mavria","year":"2006","unstructured":"Mavria G, Vercoulen Y, Yeo M, et al. ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis. Cancer Cell 2006;9:33\u201344.","journal-title":"Cancer Cell"},{"key":"487_CR31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1065-6995(02)90926-1","volume":"26","author":"G. Gliki","year":"2002","unstructured":"Gliki G, Wheeler-Jones C, Zachary I. Vascular endothelial growth factor induces protein kinase C (PKC)-dependent Akt\/PKB activation and phosphatidylinositol 3\u2032-kinase-mediates PKC delta phosphorylation: role of PKC in angiogenesis. Cell Biol Int 2002;26:751\u2013759.","journal-title":"Cell Biol Int"},{"key":"487_CR32","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0008-6363(99)00144-3","volume":"43","author":"H. Shimokawa","year":"1999","unstructured":"Shimokawa H, Seto M, Katsumata N, et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res 1999;43:1029\u20131039.","journal-title":"Cardiovasc Res"},{"key":"487_CR33","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.ATV.0000142813.33538.82","volume":"24","author":"S. Wolfrum","year":"2004","unstructured":"Wolfrum S, Dendorfer A, Rikitake Y, et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase\/ protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 2004;24:1842\u20131847.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"487_CR34","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1167\/iovs.03-1330","volume":"45","author":"K. Hirayama","year":"2004","unstructured":"Hirayama K, Hata Y, Noda Y, et al. The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes. Invest Ophthalmol Vis Sci 2004;45:3896\u20133903.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"487_CR35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.exer.2005.09.024","volume":"82","author":"M. Miura","year":"2006","unstructured":"Miura M, Hata Y, Hirayama K, et al. Critical role of the Rho-kinase pathway in TGF-beta2-dependent collagen gel contraction by retinal pigment epithelial cells. Exp Eye Res 2006;82:849\u2013859.","journal-title":"Exp Eye Res"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-007-0487-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-007-0487-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-007-0487-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:19:59Z","timestamp":1559146799000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-007-0487-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["487"],"URL":"https:\/\/doi.org\/10.1007\/s10384-007-0487-5","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}